-
ABOUT USHebei Guangxiang Pharmaceutical Co., Ltd. is specializing in the production of bulk pharmaceuticals, fine pharmaceuticals, intermediate compounds and biopharmaceutical preparations.
-
News CenterAt the forefront of corporate development, we champion the positive energy of the Four Pharmaceutical Companies: fulfilling our duties conscientiously, stepping up to the plate and taking proactive action, embracing new missions, and conducting effective new publicity. In doing so, we aim to enhance the overall competence of our employees, stimulate their enthusiasm, initiative, and creativity, and provide robust ideological guidance and powerful spiritual strength to drive the enterprise forward.
-
INNOVATIONDevelops fine, series, high-end bulk pharmaceutical intermediates and innovative bulk pharmaceutical intermediates with high added value to build variety competition advantages.
-
-
RECRUITGuangxiang has jointly established engineering laboratories, technology research centers and other high-level innovation platforms with CAS, Zhejiang University, Tianjin University and other universities.
-
CONTACTWith stable production, high-quality and reliable service, the company's products have been sold to more than 80 countries such as the United States, the United Kingdom, Germany and the Netherlands
Four Employees of Guangxiang Pharmaceutical, Shijiazhuang Sihua Pharmaceutical Group, Selected for the Provincial List of Innovative Talents in Technology-Based SMEs
Category:
TIME：2022-01-20
【SUMMARY】
Recently, the Hebei Provincial Department of Science and Technology announced the ninth batch of the “Innovative Talents of Technology-Based SMEs” list, which includes four employees from Hebei Guangxiang Pharmaceutical Co., Ltd. of Shijiazhuang Sihua Pharmaceutical Group: Cui Yongbin, Cui Xinhua, Zhang Weijin, and Ma Hui.
Recently, the Hebei Provincial Department of Science and Technology announced the ninth batch of the “Innovative Talents of Technology-Based Small and Medium-Sized Enterprises” list, which includes four employees from Hebei Guangxiang Pharmaceutical Co., Ltd. of Shijiazhuang Sihua Pharmaceutical Group: Cui Yongbin, Cui Xinhua, Zhang Weijin, and Ma Hui.
According to reports, the selection of innovative talents for technology-based SMEs is a key component of the “Double Hundred, Double Thousand” Talent Program launched by the Hebei Provincial Department of Science and Technology in 2015. This initiative is a robust measure adopted by the department to implement the “Opinions of the CPC Hebei Provincial Committee and the People’s Government of Hebei Province on Deepening Reform of the Talent Development System and Mechanism,” with the aim of encouraging enterprises to recruit high-caliber innovation and technology talent and thereby accelerating the growth of technology-based SMEs.
Talent is the primary driving force behind innovation-led development. Over the past two years, Guangxiang Pharmaceutical has placed great emphasis on leveraging the role of talent, positioning API R&D and innovation at the core of its strategy and vigorously implementing an innovation-driven development approach. By forging in-depth collaborations with leading research institutions such as Tsinghua University and Tianjin University, the company has established an enterprise-wide independent innovation system centered on industry–university–research–application linkages and focused on building technological platforms and developing new products. This initiative has pooled the collective wisdom of innovative talent and translated it into concrete actions to propel the company’s transformation and upgrading. Cui Yongbin, Chairman of Guangxiang Pharmaceutical, stated that the company will fully harness the leading and catalytic role of top innovators, anchor itself in cutting-edge areas of the industrial chain, and maintain a steadfast focus on new technologies and novel processes. Through continuous advancement in technology and innovation, the company will steadily accelerate the commercialization of research outcomes, thereby building robust momentum for its transformation, upgrading, and pursuit of differentiated competitive advantage.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
E-mail: hbgxzy@hebgxzy.com
Address: The west of Jingliu Road, lingang economic nad technological development zone, cangzhou city, Hebei province
Website
Official WeChat
e-Home
Business License
